tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Aurinia Pharmaceuticals: Strong Financial Performance and Strategic Positioning Justify Buy Rating
RatingsAurinia Pharmaceuticals: Strong Financial Performance and Strategic Positioning Justify Buy Rating
9d ago
AUPH
Aurinia Pharmaceuticals: Strong 2024 Performance and Promising Future Outlook Support Buy Rating
PremiumRatings
Aurinia Pharmaceuticals: Strong 2024 Performance and Promising Future Outlook Support Buy Rating
9d ago
AUPH
Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals
PremiumCompany Announcements
Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals
13d ago
AUPH
Aurinia Pharmaceuticals Reports Strong 2024 Financial Growth
PremiumCompany Announcements
Aurinia Pharmaceuticals Reports Strong 2024 Financial Growth
13d ago
AUPH
Aurinia Pharmaceuticals Reports Balanced Earnings with Growth and Challenges
PremiumCompany Announcements
Aurinia Pharmaceuticals Reports Balanced Earnings with Growth and Challenges
13d ago
AUPH
Aurinia Pharmaceuticals Reports Strong Financial Growth in 2024
PremiumCompany AnnouncementsAurinia Pharmaceuticals Reports Strong Financial Growth in 2024
13d ago
AUPH
Aurinia Pharmaceuticals Files Form 8-K Indicating Key Corporate Event
Premium
Company Announcements
Aurinia Pharmaceuticals Files Form 8-K Indicating Key Corporate Event
13d ago
AUPH
Aurinia Pharmaceuticals reports Q4 EPS 1c, consensus (2c)
Premium
The Fly
Aurinia Pharmaceuticals reports Q4 EPS 1c, consensus (2c)
13d ago
AUPH
Aurinia Pharmaceuticals sees 2025 revenue $250M-$260M, consensus $274.4M
PremiumThe Fly
Aurinia Pharmaceuticals sees 2025 revenue $250M-$260M, consensus $274.4M
13d ago
AUPH
Aurinia Pharmaceuticals (AUPH) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Aurinia Pharmaceuticals (AUPH) Q4 Earnings Cheat Sheet
15d ago
AUPH
Aurinia Pharmaceuticals to Announce 2024 Financial Results and Business Update
PremiumCompany Announcements
Aurinia Pharmaceuticals to Announce 2024 Financial Results and Business Update
20d ago
AUPH
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ANAB
AUPH
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
KOD
AGIO
Aurinia Pharmaceuticals Celebrates New Lupus Nephritis Guidelines
Premium
Company Announcements
Aurinia Pharmaceuticals Celebrates New Lupus Nephritis Guidelines
4M ago
AUPH
Aurinia Highlights Lupus Nephritis Breakthroughs at ACR 2024
Premium
Company Announcements
Aurinia Highlights Lupus Nephritis Breakthroughs at ACR 2024
4M ago
AUPH
Aurinia Pharmaceuticals Engages at London Conference
PremiumCompany Announcements
Aurinia Pharmaceuticals Engages at London Conference
4M ago
AUPH
Aurinia Pharmaceuticals Reports Strong Growth and Strategic Restructuring
PremiumCompany Announcements
Aurinia Pharmaceuticals Reports Strong Growth and Strategic Restructuring
4M ago
AUPH
Unusually active option classes on open November 7th
PremiumThe Fly
Unusually active option classes on open November 7th
4M ago
BAX
CRM
Aurinia Pharmaceuticals Reports Strong Q3 Growth and Restructuring
PremiumCompany Announcements
Aurinia Pharmaceuticals Reports Strong Q3 Growth and Restructuring
4M ago
8K
AUPH
Aurinia Pharmaceuticals reports Q3 EPS 10c, consensus 1c
PremiumThe FlyAurinia Pharmaceuticals reports Q3 EPS 10c, consensus 1c
4M ago
AUPH
AUPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AUPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
AUPH
Aurinia Pharmaceuticals Showcases LUPKYNIS’s Impact at ASN 2024
Premium
Company Announcements
Aurinia Pharmaceuticals Showcases LUPKYNIS’s Impact at ASN 2024
5M ago
AUPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >